TPC
Takeda Pharmaceutical Company Portfolio holdings
AUM
$19.6M
This Quarter Return
+6.99%
1 Year Return
-13.61%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$289M
AUM Growth
+$289M
(-12%)
Cap. Flow
-$49.6M
Cap. Flow
% of AUM
-17.16%
Top 10 Holdings %
Top 10 Hldgs %
98.97%
Holding
15
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Day One Biopharmaceuticals
DAWN
|
$1.42M |
Top Sells
| 1 |
Phathom Pharmaceuticals
PHAT
|
$45.7M |
| 2 |
Shattuck Labs
STTK
|
$5.27M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
HilleVax
HLVX
$105M
| $112M | 38.69% | 6,724,000 | – | – |
|
2
Denali Therapeutics
DNLI
$2.23B
| $86.5M | 29.92% | 4,214,559 | – | – |
|
|
3
Phathom Pharmaceuticals
PHAT
$864M
| $33.5M | 11.59% | 3,153,217 -4,306,069 | -58% | -$45.7M |
|
4
Ovid Therapeutics
OVID
$91M
| $23M | 7.95% | 7,531,996 | – | – |
|
|
5
Shattuck Labs
STTK
$47M
| $13.4M | 4.64% | 1,501,061 -589,797 | -28% | -$5.27M |
|
6
Wave Life Sciences
WVE
$1.53B
| $8.31M | 2.88% | 1,346,892 | – | – |
|
7
Equillium
EQ
$62.2M
| $4.22M | 1.46% | 1,824,977 | – | – |
|
|
TSBX
8
DELISTED
Turnstone Biologics
TSBX
| $2.35M | 0.81% | 895,824 | – | – |
|
9
Xilio Therapeutics
XLO
$36.3M
| $1.59M | 0.55% | 1,475,121 | – | – |
|
|
10
Day One Biopharmaceuticals
DAWN
$769M
| $1.42M | 0.49% | +85,840 | New | +$1.42M |
|
11
American Well
AMWL
$111M
| $1.26M | 0.44% | 1,554,669 | – | – |
|
12
Rani Therapeutics
RANI
$24.4M
| $1.05M | 0.36% | 338,679 | – | – |
|
|
JBIO
13
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $402K | 0.14% | 13,580 | – | – |
|
|
AKLI
14
DELISTED
Akili, Inc. Common Stock
AKLI
| $214K | 0.07% | 738,819 | – | – |
|
15
Standard BioTools
LAB
$481M
| $44.8K | 0.02% | 16,515 | – | – |
|